Corporate VC

Ramot at Tel Aviv University

Investment Details

Investor Type
Corporate VC

Asset Class Focus
Venture Capital, Private Equity

Stage Focus
Seed, Early Stage, Growth, Late Stage

Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, France, Italy, Denmark, Switzerland, Spain, Austria, Netherlands, Sweden, Belgium, Israel, Norway, Finland

Industries Focus

  • Technology
  • Healthcare
  • Energy
  • Agriculture
  • Artificial Intelligence
  • Pharmaceuticals
  • Medical Devices
  • Cybersecurity
  • Robotics
  • Food Technology
  • Quantum Computing
  • Biotechnology
  • Environmental Technology
  • Materials Science
  • Nanotechnology

Investment Size:
500,000 to 5,000,000 USD

Investor Details Founded: 1973

Ramot at Tel Aviv University is the technology transfer company of Tel Aviv University, responsible for commercializing the university's innovations and fostering startups. It serves as a bridge between academic research and industry, facilitating the translation of scientific discoveries into marketable products and services. Ramot's mission is to build and foster a portfolio of sustainable assets through licensing its technologies and intellectual property to new companies established on TAU techs/IP and existing companies, generating revenue for TAU and its researchers while adding value to society.

Ramot's activities include securing intellectual property protection for TAU inventions, bridging the gap between early technologies and the market, and actively managing and promoting its portfolio assets and companies. It aims to be the innovation hub of choice for its existing and new partners. The company has established collaborations with international companies such as Pfizer, Teva, Bayer, Samsung, Google, Microsoft, Merck, Novartis, and GSK, among others.

Through its efforts, Ramot has filed over 5,000 patent applications claiming more than 1,300 inventions, leading to the establishment of over 100 startup companies and more than 200 licenses and option agreements with commercial partners. Notable products resulting from these collaborations include the USB flash drive, developed in partnership with M-Systems, and medical therapies for conditions such as Alzheimer's, Parkinson's, cancer, and diabetes. Ramot continues to play a pivotal role in translating academic research into practical applications that benefit society.

Requirements
  • Innovative technologies with commercial potential
  • Strong intellectual property protection
  • Collaborative partnerships with industry leaders
  • Commitment to societal impact through commercialization
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • QArt Medical
  • Unispectral
  • Trobix
  • Multivu
  • Silib
  • Tubilux Pharma
  • Neurim Pharmaceuticals
  • Blistex Inc.
  • SanDisk
  • Pfizer
  • Teva
  • Bayer
  • Samsung
  • Google
  • Microsoft
  • Merck
  • Novartis
  • GSK
Claim this Investor

Are you an official representative of Ramot at Tel Aviv University?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim